Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Palvella Therapeutics (PVLA)

Palvella Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PVLA
DateTimeSourceHeadlineSymbolCompany
04/03/202513:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PVLAPalvella Therapeutics Inc
25/02/202513:00GlobeNewswire Inc.Palvella Therapeutics to Present at the TD Cowen 45th Annual Healthcare ConferenceNASDAQ:PVLAPalvella Therapeutics Inc
18/02/202521:39Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PVLAPalvella Therapeutics Inc
10/02/202523:25Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:PVLAPalvella Therapeutics Inc
10/02/202523:00Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:PVLAPalvella Therapeutics Inc
10/02/202522:40Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:PVLAPalvella Therapeutics Inc
10/02/202522:21Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:PVLAPalvella Therapeutics Inc
10/02/202513:00GlobeNewswire Inc.Palvella Therapeutics to Expand Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations to Include the Younger Pediatric Population, Children 3 to 5 Years OldNASDAQ:PVLAPalvella Therapeutics Inc
07/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
07/02/202521:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
07/02/202521:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
07/02/202521:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
17/01/202521:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PVLAPalvella Therapeutics Inc
17/01/202505:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PVLAPalvella Therapeutics Inc
10/01/202513:00GlobeNewswire Inc.Palvella Therapeutics Announces Publication of Results from Phase 2 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations in the Journal of Vascular AnomaliesNASDAQ:PVLAPalvella Therapeutics Inc
08/01/202520:04Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PVLAPalvella Therapeutics Inc
08/01/202513:00GlobeNewswire Inc.Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous MalformationsNASDAQ:PVLAPalvella Therapeutics Inc
06/01/202521:59Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PVLAPalvella Therapeutics Inc
31/12/202411:04Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PVLAPalvella Therapeutics Inc
20/12/202422:32Edgar (US Regulatory)Form SCHEDULE 13D - General Statement of Acquisition of Beneficial OwnershipNASDAQ:PVLAPalvella Therapeutics Inc
20/12/202421:59Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:PVLAPalvella Therapeutics Inc
18/12/202401:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
18/12/202401:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
18/12/202401:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
18/12/202401:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
18/12/202401:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PVLAPalvella Therapeutics Inc
17/12/202421:22Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:PVLAPalvella Therapeutics Inc
13/12/202419:55GlobeNewswire Inc.Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 MillionNASDAQ:PVLAPalvella Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PVLA